Who is affected and how:

• Research entities (universities, academic health centers, private and government labs, biotech firms): Directly affected; they must collect and report annual, species-specific counts of animals bred, housed, and used, and document pain classifications and use of analgesia. Expect added administrative work to track, validate, and submit standardized data each year.

• Institutional animal care and use committees (IACUCs) / animal care committees: Will receive the submitted forms from NIH for local oversight, enabling review of aggregated annual data for their institution.

• NIH (Director and staff): Must receive forms, distribute them to local oversight committees, build or expand an online searchable public database, and post each filing within three months; NIH will need staff time and IT resources to implement and maintain the database and manage submissions.

• The public, animal welfare and advocacy groups, and journalists: Gain improved, regular access to standardized information about animal use across reporting institutions, which can inform oversight, policy advocacy, and public debate.

• Research programs and investigators: May face greater scrutiny and transparency; institutions may need to allocate staff time to recordkeeping and compliance. Concerns may arise about how publicly posted data affect proprietary research or security-sensitive programs; the text does not specify exemptions.

Overall effects:

• Increases transparency and public oversight of animal use in research by creating a centralized, searchable record of annual species-level counts and pain/analgesia data.
• Imposes administrative and IT burdens on research institutions and NIH to collect, validate, and publish data; the bill does not specify funding to offset those costs.
• May prompt institutions to improve recordkeeping and internal compliance processes; may also raise debates over data definitions, scope, and any needed exemptions for confidential or security-sensitive research.